NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

JAYEX TECHNOLOGY LIMITED (JTL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of JTL: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000155293
Address: Level 4, 100 Albert Road South Melbourne VIC 3205
Tel:  +61 1300 799 365Fax: +61 03 9077 9233

Date first listed: 17/12/2015

Sector: Health Care Equipment & Services Industry Group: XHJ

News & Events

Expand this box to read and print

The suspension of trading in the securities of Jayex Technology Limited will be lifted from the commencement of trading on Monday, 6 May 2024 following lodgement of its Annual Report for the period ending 31 December 2023.

03/05/2024

The company releases its Appendix 4G and Corporate Governance Statement.

03/05/2024

The company releases its annual report.

03/05/2024

The securities of the company will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Tuesday, 2 April 2024, for not lodging the relevant periodic report by the due date. If the report is lodged between the closure of the market announcements office on Thursday, 28 March 2024, and the imposition of the suspension, the entity's securities will normally be reinstated to quotation on the next trading day after the suspension is imposed.

02/04/2024

The securities of Jayex Technology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of JTL, pending the release of its Annual Report for the year ended 31 December 2023.

28/03/2024

The suspension of trading in the securities of Jayex Technology Limited will be lifted from the commencement of trading on Friday, 30 July 2021 following the release by JTL of an announcement regarding a strategic investment.

30/07/2021

Jayex has signed a binding agreement for the investment of US$2 Million in cash into Brainworks' Foundry, Inc. Brainworks' AI technology platform is currently undergoing preliminary clinical trials and is designed to allow a patient's vital signs, incl. heart rate, respiratory rate, blood oxygenation to be measured simply by focusing a smart camera (phone, PC, TV) on the patient's face for 5-30 seconds. In addition, Brainworks has utilized existing technologies to develop a highly scalable polymerase chain reaction testing process, using next-generation gene sequencing and DNA barcoding that reduces cost and turnaround time. Post-COVID, Brainworks plans to diversify its platform to support additional viral and bacterial tests including influenza, Hepatitis, HIV, and other pathologies.

30/07/2021

The securities of Jayex Technology Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of JTL, pending the release of an announcement regarding a strategic investment.

28/07/2021

name changed from Jayex Healthcare Limited

01/06/2021

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    04/04/2023Michael Boyd3,000,000$0.010$31,267
    01/12/2022Michael Chan50,820$0.012$610
    30/06/2021Michael Chan20,000$0.027$540
    30/09/2020Michael Boyd1,500,000$0.035$52,500
    30/06/2020Michael Chan24,962$0.018$449

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Michael BoydExecutive Chairman17/12/2015
    Robert HadleyCEO, CFO03/10/2022
    Brian RenwickNon Exec Director17/12/2015
    William BoydNon Exec Director04/06/2024
    Melanie LeydinCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Michael ChanNon Exec Director27/03/201704/06/2024
    Nick HarperNon Exec Director02/09/202013/03/2024
    Nathan WoodardCFO28/08/201831/01/2023
    Nick FernandoManaging Director, CEO23/05/201725/07/2020
    Agam JainNon Exec Director14/01/201606/12/2019
    Cameron KnoxCFO15/01/201628/08/2018
    John AllinsonNon Exec Director17/12/201529/07/2016
    Shane TannerNon Exec Director17/12/201512/07/2016

    Date of first appointment, title may have changed.